Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Qiao, D.
Right arrow Articles by Martinez, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiao, D.
Right arrow Articles by Martinez, J. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 6, 957-964, June 2001
© 2001 Oxford University Press


CARCINOGENESIS

Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation

Dianhua Qiao, Supriya V. Gaitonde, Wenqing Qi and Jesse D. Martinez,1

Arizona Cancer Center, Department of Radiation Oncology, University of Arizona, Tucson, AZ 85724, USA

Bile acids, principally deoxycholic acid (DCA), have been implicated in the promotion of colon tumorigenesis in both animals and humans. Increasing evidence suggests that bile acids may exert their tumor promoting activity by modulating intracellular signaling and altering gene expression. In this study we have investigated the effect of bile acids on the tumor suppressor p53 using the human colon tumor cell line HCT116, which retains the wild-type p53 gene and functional p53 signaling in response to DNA damage. We found that exposure of the cells to elevated concentrations of DCA suppressed accumulation of p53 protein as well as p53 transactivation and impaired the p53 response of the cells to DNA damaging agents, such as ionizing radiation. Neither ursodeoxycholic acid, a putative chemopreventive agent, nor cholic acid, which is biologically inert, had any effect on p53 protein level and transactivation activity. Further examination revealed that instead of inhibition, DCA induced p53 mRNA in a dose-dependent manner, indicating that the inhibitory effect of DCA on p53 protein is mediated by a post-transcriptional mechanism. Both lactacystin, a specific inhibitor of the 26S proteasome, and leptomycin B, a specific inhibitor of the nuclear export protein CRM1, could block the effect that DCA had on p53 protein levels, suggesting that DCA suppressed p53 by stimulating the process of proteasome-mediated degradation of p53. Significantly, blocking extracellular signal-regulated kinase (ERK) signaling, but not protein kinase C (PKC), blunted suppression by DCA of p53 protein levels and transactivation activity, suggesting that DCA suppressed p53, in part, by stimulating the ERK signaling pathway. Both ERK and PKC signaling have been previously demonstrated to be stimulated by DCA. These results suggest a novel signaling mechanism of bile acids that may play an important role in colon tumor promotion mediated by bile acids.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. Zhou, M. Liu, Y. Zhai, and W. Xie
The Antiapoptotic Role of Pregnane X Receptor in Human Colon Cancer Cells
Mol. Endocrinol., April 1, 2008; 22(4): 868 - 880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Roman, A. Petre, A. Thepot, A. Hautefeuille, J.-Y. Scoazec, F. Mion, and P. Hainaut
Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture
Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G45 - G53.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Jean-Louis, S. Akare, M. A. Ali, E. A. Mash Jr., E. Meuillet, and J. D. Martinez
Deoxycholic Acid Induces Intracellular Signaling through Membrane Perturbations
J. Biol. Chem., May 26, 2006; 281(21): 14948 - 14960.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Muhlbauer, B. Allard, A. K. Bosserhoff, S. Kiessling, H. Herfarth, G. Rogler, J. Scholmerich, C. Jobin, and C. Hellerbrand
Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-{kappa}B signal transduction and IL-8 gene expression in colonic epithelial cells
Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G1000 - G1008.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. S. Yang, K.-V. Chin, and J. D. Lambert
Cancer Chemoprevention by Targeting Proteasomal Degradation: Commentary re KA Dragnev et al, Specific Chemopreventive Agents Trigger Proteasomal Degradation of G1 Cyclins: Implications for Combination Therapy. Clin Cancer Res, 2004;10:2570-7
Clin. Cancer Res., April 1, 2004; 10(7): 2220 - 2221.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Fickert, M. Trauner, A. Fuchsbichler, C. Stumptner, K. Zatloukal, and H. Denk
Bile Acid-Induced Mallory Body Formation in Drug-Primed Mouse Liver
Am. J. Pathol., December 1, 2002; 161(6): 2019 - 2026.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.